Rchr
J-GLOBAL ID：202201015352033101
Update date: Dec. 06, 2024
Emori Makoto
エモリ マコト | Emori Makoto
Affiliation and department：
Research field (1)：
Orthopedics
Research theme for competitive and other funds (5)：
- 2024 - 2027 Establishment of new treatment method for dedifferentiated chondrosarcoma
- 2023 - 2026 プロテオーム解析による骨肉腫の肺転移機序解明と新規治療開発
- 2020 - 2023 ショットガンプロテオミクスを用いた神経線維腫の悪性化機序解明と治療への応用
- 2018 - 2021 Investigation of draggable fusion genes and diagnostic biomarker in bone and soft tissue sarcoma
- 2017 - 2020 Establishment of the testing targeted for CD109 antigen in soft tissue sarcoma
Papers (90)：
-
Naoya Nakahashi, Makoto Emori, Kohichi Takada, Yasutaka Murahashi, Junya Shimizu, Kazuyuki Murase, Tomohide Tsukahara, Shintaro Sugita, Akira Takasawa, Kousuke Iba, et al. Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS. Human Cell. 2024. 38. 1
-
Mizuki Aketo, Makoto Emori, Kohichi Takada, Kazuyuki Murase, Yohei Arihara, Junya Shimizu, Yasutaka Murahashi, Masahiko Okamoto, Shintaro Sugita, Atsushi Teramoto. Secondary Osteosarcoma After Carbon-Ion Radiotherapy for Desmoid-Type Fibromatosis: A Case Report. Cancer Reports. 2024. 7. 11
-
Norito Suzuki, Masashi Idogawa, Makoto Emori, Kazuyuki Murase, Yohei Arihara, Hajime Nakamura, Makoto Usami, Tomohiro Kubo, Ichiro Kinoshita, Shintaro Sugita, et al. LMNA::NTRK1 Fusion-positive Leiomyosarcoma: Discrepancy between DNA-based Comprehensive Genomic Profiling and RNA Sequencing. Internal medicine (Tokyo, Japan). 2024. 63. 15. 2215-2219
-
Yusuke Akane, Masaki Yamamoto, Akira Takebayashi, Ryo Hamada, Keita Igarashi, Makoto Emori, Shintaro Sugita, Kohichi Takada, Tadashi Hasegawa, Takeshi Tsugawa. Crizotinib therapy for congenital embryonal rhabdomyosarcoma associated with an <i>ATIC-ALK</i> gene fusion. Pediatric Blood & Cancer. 2024
-
Shuto Hamada, Tomohide Tsukahara, Yuto Watanabe, Kenji Murata, Yuka Mizue, Terufumi Kubo, Takayuki Kanaseki, Yoshihiko Hirohashi, Makoto Emori, Munehide Nakatsugawa, et al. Development of T cell receptor-engineered T cells targeting the sarcoma-associated antigen papillomavirus binding factor. Cancer science. 2024. 115. 1. 24-35
ｍore...
MISC (1)：
-
清水 淳也, 江森 誠人, 高島 弘幸, 土江 博幸, 村橋 靖崇, 水島 衣美, 山下 敏彦. 脱分化脂肪肉腫における脂肪成分領域割合は予後を予測できる. 日本整形外科学会雑誌. 2019. 93. 6. S1438-S1438
Return to Previous Page
